Close Menu

NEW YORK – Experts involved in the Clinical Interpretation of Variants in Cancer (CIViC) database are in discussions with the US Food and Drug Administration about garnering regulatory recognition for the repository. 

CIViC was launched four years ago by brothers Obi and Malachi Griffith at Washington University School of Medicine, St. Louis, as an open-source, open-access repository of variants that the life sciences community could curate and interpret collaboratively, and use to advance precision cancer medicine. 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).